Introduction Eli Lilly is a company that specializes in the research, development, production, and marketing of pharmaceutical products. The company operates in many countries and distributes its products globally. In addition to human healthcare, Eli Lilly also conducts research in the field of animal health to develop treatments for diseases and improve the efficiency of animal food production. The company's manufacturing and distribution facilities are located in the United States, Puerto Rico, and other countries around the world. |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 126 |
Monoclonal antibody | 32 |
Diagnostic radiopharmaceuticals | 13 |
AAV based gene therapy | 11 |
Hormone | 10 |
Target |
Mechanism 3pE-modified Aβ inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date02 Jul 2024 |
Target |
Mechanism IL15R agonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date22 Apr 2024 |
Target |
Mechanism IL-13 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. EU [+3] |
First Approval Date16 Nov 2023 |
Start Date01 Sep 2024 |
Sponsor / Collaborator |
Start Date08 Aug 2024 |
Sponsor / Collaborator |
Start Date01 Aug 2024 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Vinblastine Sulfate ( Tubulin ) | Hodgkin's Lymphoma More | Approved |
Insulin Glargine(Boehringer Ingelheim) ( INSR ) | Diabetes Mellitus, Type 2 More | Approved |
Procaine merethoxylline ( Sodium channels ) | - | Approved |
Teriparatide ( PTH1R ) | Primary osteoporosis More | Approved |
Fluoxetine Hydrochloride/Olanzapine ( D1 receptor x D2 receptor x SERT ) | Depressive Disorder, Treatment-Resistant More | Approved |